Improved survival in an Asian cohort of young colorectal cancer patients: an analysis of 523 patients from a single institution

Int J Colorectal Dis. 2009 Sep;24(9):1075-83. doi: 10.1007/s00384-009-0701-7. Epub 2009 Apr 23.

Abstract

Background: Colorectal cancer (CRC) in the young is rare. Outcomes remain varied compared to older populations. The study reviews characteristics and overall survival (OS) of CRC in patients < or =50 years old.

Materials and methods: Five hundred and twenty-three (14%) of 3,796 sporadic CRCs were identified. Patients were compared for demographics, tumour characteristics, treatment, and 5-year overall specific survival. Independent prognostic factors were evaluated.

Results: The majority were males (54%) with a median age of 45 years (range 19-50 years). Sixty-three percent of the patients presented with advanced stage disease (stage III and IV), and tumours were predominantly left-sided (83%). A higher frequency of mucinous or signet ring cell histological subtypes (16% vs 9%, p = 0.028) as well as poorly differentiated tumours (30% vs 12%, p = 0.0001) were present in younger patients < or =40 years. With a median follow-up of 41 months, the 5-year OS is 58% (95% confidence interval 53-64%). Younger patients < or =40 years had significantly superior 5-year OS of 62% vs 58% in the age group 41-50 years old (p = 0.004). Multivariate analysis identified five independent prognostic features: age group of 41-50 years, poorly differentiated tumour grade, presence of perineural infiltration, high tumour stage, and carcinoembryonic antigen values > or =5 ng/ml.

Conclusion: This study has revealed significantly improved 5-year survival in young CRC compared to those reported in the literature.

MeSH terms

  • Adult
  • Age Factors
  • Asia
  • Carcinoembryonic Antigen
  • Cohort Studies
  • Colorectal Neoplasms / diagnosis
  • Colorectal Neoplasms / epidemiology*
  • Colorectal Neoplasms / mortality
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Prognosis
  • Survival Rate
  • Young Adult

Substances

  • Carcinoembryonic Antigen